Rabivax-S

Phase 2Biologic

RRoss University School of Veterinary Medicine

Rabivax-S is one of 21 biologic programs targeting Malaria. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MalariaActive, not recruiting

MalariaPhase 2

Active, not recruiting

Competition

Competitive Landscape

479 competitors in Malaria

#DrugCompanyPhaseTrials

Biltricide

Bayer

Preclinical

1 2

Stelara

Johnson & Johnson

Preclinical

—3

Rabivax-S

RRoss University School of Veterinary Medicine

Phase 2

2 4

Hydroxychloroquine Sulfate

Novartis

Preclinical

—5

Iron

WWatson Pharmaceuticals

Preclinical

1 6

IV LBH589

Novartis

Preclinical

1 7

Mefloquine Plus Artesunate

Medicines for Malaria Venture

Preclinical

1 8

IV Ceftriaxone

RRESnTEC, Institute of Research

Preclinical

1 9

RTS,S/AS01E

GSK

Preclinical

4 10

Malarone

Medicines for Malaria Venture

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

Phase 2Active, not recruiting

Malaria

NCT07183371

Q4 2027

Phase 2Active, not recruiting

Malaria

NCT07147400

Clinical

Trials by Indication[1]

Malaria2 trials

A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M

Active, not recruiting·UUniversity of Oxford·Phase 2·NCT07183371·360 enrolled

Phase 2 Randomized, Double-blind, Controlled Study of Pfs230D1-CRM197 With R21 in Matrix-M1 in Healthy African School Children and Adults

Active, not recruiting·SSerum Institute of India Pvt. Ltd.·Phase 2·NCT07147400·1,200 enrolled

Vaccine1 trial

Non-specific Effects of Rabies Vaccine

Completed·RRoss University School of Veterinary Medicine·Phase 4·NCT03656198·546 enrolled

Prophylaxis1 trial

Safety of Rabivax-S for Pre-exposure Prophylaxis

Completed·RRoss University School of Veterinary Medicine·Phase 4·NCT03741270·159 enrolled

Immunogenicity1 trial

Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally

Completed·VVietnam Military Medical University·Phase 4·NCT05937113·220 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Rabivax-S. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Rabivax-S compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Rabivax-S. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ross University School of Veterinary Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 2[1]
Company: RRoss University School of Veterinary Medicine

Rabivax-S

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Q4 2027

Trials by Indication[1]

Malaria2 trials

Vaccine1 trial

Prophylaxis1 trial

Immunogenicity1 trial

References

Drug Info

Quick Facts

Related News